Copyright © 2001 by the European Society of Cardiology.
Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?
a Cardiology Division, Medical Center of Pavia, S. Maugeri Foundation, Institute of Care and Scientific Research, Pavia, Italy
c Heart Failure Unit, Medical Center of Montescano (PV), Montescano, Italy
b Department of Biomedical Engineering, Medical Center of Montescano (PV), Montescano, Italy
d Policlinico S. Matteo,>Institute of Care and Scientific Research, Cardiology Department, Pavia, Italy
revised June 6, 2000; accepted June 7, 2000
Abstract
Aims The 6-min walk test has been incorporated into studies on the efficacy of new therapies and into prognostic stratification for chronic heart failure patients. Firm conclusions on the usefulness of the test in clinical practice are still lacking. The aim of this study was to investigate (1) the correlation between walk test performance and standard indices of cardiac function and exercise capacity, and (2) the prognostic value of the walk test with respect to peak VdotO2and NYHA class.
Methods and Results Three hundred and fifteen chronic heart failure patients (age: 53±9 years, NYHA class: II (182), III (133)) underwent a functional evaluation and a 6-min walk test. Of these, 270 were followed-up for a minimum of 6 months (mean 387±177 days). Walked distance was 396±92m. There was no significant correlation between distance walked and central haemodynamic data. Functional capacity, as measured by ergometry, correlated moderately with distance walked (duration: r=0·48, peak VdotO2: r=0·59, anaerobic threshold: r=0·54; all P<0·001). During follow-up, 46 patients died from cardiovascular causes and 12 were urgently transplanted. Either of these events were considered end points of the study. Survival analysis was performed from a continuous walk test and peak VdotO2measurements or after categorization of (a) quartile segmentation, (b) cut-off points from the literature and (c) thresholds from receiver operating characteristic curves. At univariate survival analysis (Cox regression), the association of the walk test with survival was of significance (P=0·03, continuous variable), or borderline significance (0·05
P0·1, after categorization). Peak VdotO2was always significant, indepedent of the scale used (0·005P0·03). The strongest association was found for NYHA class (P<0·001), which showed the highest sensitivity and specificity for the prediction of the event (0·64 and 0·65, respectively). When walk test performance, continuous or categorized, was entered into a multivariate model with NYHA class or peak VdotO2, it lost any significant association with survival (P>0·76 in all models with NYHA class andP >0·27 in all models with peak VdotO2).
Conclusion In moderate-to-severe chronic heart failure patients, the 6-min walk test is not related to cardiac function and only moderately related to exercise capacity. Walking performance does not provide prognostic information which can complement or substitute for that provided by peak VdotO2or NYHA class. Hence the test is of limited usefulness as a decisional indicator in clinical practice.
Key Words: Heart failure, prognosis, exercise, walk test, risk factors
f1 Correspondence: Dr Cristina Opasich, Fondazione S. Maugeri, Divisione di Cardiologia, Via Ferrata 4, I-27100 Pavia, Italy.
References
- Guyatt GH, Thompson PJ, Berman LB. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis. 1985;28:517–524
- Lipkin DP, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ. 1988;292:653–655
- Dracup K, Walden JA, Stevenson LW, Brecht ML. Quality of life in patients with advanced heart failure. J Heart and Lung Transplant. 1992;11:273–279
- Paker M, Gheorghiade M, Young JB. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin converting enzyme inhibitors. N Engl J Med. 1993;329:1–7
[Abstract/Free Full Text] - Uretsky BF, Young JB, Shahidi E, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED Trial. J Am Coll Cardiol. 1993;22:955–962[Abstract]
- Califf RM, Adams KF, McKenna WJ. A randomized trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997;134:44–54[CrossRef][Web of Science][Medline]
- Circulation. 1995;92:212–218
[Abstract/Free Full Text] - Packer M, Bristow ML, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355
[Abstract/Free Full Text] - Metra M, Nardi M, Giubbini R, Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994;24:1678–1687[Abstract]
- Krum H, Sackner-Bernstein JD, Goldsmith RL. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in severe chronic heart failure. Circulation. 1995;92:1499–1506
[Abstract/Free Full Text] - Olsen SL, Gilbert EM, Renlund DG. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol. 1995;25:1225–1231[Abstract]
- Meyer K, Scwaibold M, Westbrooh S. Effects of exercise training and activity restriction on 6-minute walking test performance in patients with chronic heart failure. Am Heart J. 1997;133:447–453[CrossRef][Web of Science][Medline]
- Bittner V, Weiner D, Yusuf S. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270:1702–1707
[Abstract/Free Full Text] - Cahalin L, Mathier M, Semigran M, Dec W, DiSalvo T. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest. 1996;110:325–332
[Abstract/Free Full Text] - Roul G, Germain P, Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J. 1998;136:449–457[CrossRef][Web of Science][Medline]
- Swedberg K, Califf RM, Adams K. Six minute walk test gives prognostic information in severe heart failure. J Am Coll Cardiol. 1995;25:329A
- Zugck C, Kruger C, Durr S. Is the 6-minute walking test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J. 2000;21:540–549
[Abstract/Free Full Text] - Lucas C, Stevenson LW, Johnson W. The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J. 1999;138:618–624[CrossRef][Web of Science][Medline]
- Bittner V. Determining prognosis in congestive heart failure: role of the 6-minute walk test. Am Heart J. 1999;138:593–596[CrossRef][Web of Science][Medline]
- Poole-Wilson PA. The 6-minute walk. A simple test with clinical application. Eur Heart J. 1999;21:507–508
- Willenheimer R, Erhardt LR. Value of the 6-min walk test for assessment of severity and prognosis of heart failure. Lancet. 2000;355:515–516[CrossRef][Web of Science][Medline]
- Opasich C, Pinna GD, Mazza A. Reproducibility of the six-minute walking test in chronic congestive heart failure patients: practical implications. Am J Cardiol. 1998;81:1497–1500[CrossRef][Web of Science][Medline]
- Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–843
[Abstract/Free Full Text] - Parmar MKB, Machin D. Survival analysis. A practical approach. New York: John Wiley & Sons; 1996.
- Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connel JB. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92:3593–3612
[Abstract/Free Full Text] - Harrington D, Coats A. Mechanisms of exercise intolerance in congestive heart failure. Curr Opin in Cardiol. 1997;12:224–232
- Katz S, Mancini D, Jondeau G. Physiological determinants of maximal and submaximal exercise capacity in normal subjects and patients with heart failure. Heart Failure. 1996;236:
- Faggiano P, D'Aloia A, Gualeni A, Lavatelli A, Giordano A. Assessment of oxygen uptake during the 6-minute walk test in patients with heart failure: preliminary experience with a portable device. Am Heart J. 1997;134:203–206[CrossRef][Web of Science][Medline]
- Riley M, McParland J, Stanford CF, Nicholls DP. Oxygen consumption during corridor walk testing in chronic cardiac failure. Eur Heart J. 1992;13:789–793
[Abstract/Free Full Text] - Foray A, Williams D, Reemtsma K, Oz M, Mancini D. Assessment of submaximal exercise capacity in patients with left ventricular assist devices. Circulation. 1996;Suppl II:II222–226
- Cahalin LP, Semigran MJ, Dec GW. Assessment of oxygen uptake during the six-minute walk test. Chest. 1997;111:1465–1466
[Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. A. Castel, F. Mendez, D. Tamborero, L. Mont, S. Magnani, J. M. Tolosana, A. Berruezo, M. Godoy, M. Sitges, B. Vidal, et al. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy Europace, March 1, 2009; 11(3): 338 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Smith, M. Vennelle, R. S. Gardner, T. A. McDonagh, M. A. Denvir, N. J. Douglas, and D. E. Newby Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial Eur. Heart J., May 2, 2007; 28(10): 1221 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Buckberg Invited commentary Ann. Thorac. Surg., April 1, 2007; 83(4): 1387 - 1388. [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Chung, L. Shemanski, D. G. Sherman, H. L. Greene, D. B. Hogan, J. C. Kellen, S. G. Kim, L. W. Martin, Y. Rosenberg, D. G. Wyse, et al. Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial Fibrillation: Results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1891 - 1899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Herrmann, I. Kindermann, S. Muller, T. Georg, M. Kindermann, M. Bohm, and W. Herrmann Relationship of Plasma Homocysteine with the Severity of Chronic Heart Failure Clin. Chem., August 1, 2005; 51(8): 1512 - 1515. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Opasich, S. De Feo, G. D. Pinna, G. Furgi, R. Pedretti, D. Scrutinio, and R. Tramarin Distance Walked in the 6-Minute Test Soon After Cardiac Surgery: Toward an Efficient Use in the Individual Patient Chest, December 1, 2004; 126(6): 1796 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Faggiano, A. D'Aloia, A. Gualeni, L. Brentana, and L. D. Cas The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature Eur J Heart Fail, October 1, 2004; 6(6): 687 - 691. [Full Text] [PDF]
|
|
|
|
 |
|
 F.X Kleber, P Waurick, and M Winterhalter CPET in heart failure Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D1 - D4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Willems and K. R Sipido Nonexcitatory stimulation as a novel treatment for heart failure: cause for excitement? Eur. Heart J., April 2, 2004; 25(8): 626 - 628. [Full Text] [PDF]
|
|
|
|
|
|
C. Schalcher, H. Rickli, M. Brehm, D. Weilenmann, E. Oechslin, W. Kiowski, and H. P. Brunner-La Rocca Prolonged Oxygen Uptake Kinetics During Low-Intensity Exercise Are Related to Poor Prognosis in Patients With Mild-to-Moderate Congestive Heart Failure Chest, August 1, 2003; 124(2): 580 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bittner Exercise testing in heart failure: Maximal, submaximal, or both? J. Am. Coll. Cardiol., July 2, 2003; 42(1): 123 - 125. [Full Text] [PDF]
|
|
|
|
|
|
A. Ohlsson, D. Steinhaus, B. Kjellstrom, L. Ryden, and T. Bennett Central hemodynamic responses during serial exercise tests in heart failure patients using implantable hemodynamic monitors Eur J Heart Fail, June 1, 2003; 5(3): 253 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G Lainchbury and A M. Richards EXERCISE TESTING IN THE ASSESSMENT OF CHRONIC CONGESTIVE HEART FAILURE Heart, December 1, 2002; 88(5): 538 - 543. [Full Text] [PDF]
|
|
|
|
|
|
A. Radzewitz, E. Miche, G. Herrmann, M. Nowak, U. Montanus, U. Adam, Y. Stockmann, and M. Barth Exercise and muscle strength training and their effect on quality of life in patients with chronic heart failure Eur J Heart Fail, October 1, 2002; 4(5): 627 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Mejhert, E Linder-Klingsell, M Edner, T Kahan, and H Persson Ventilatory variables are strong prognostic markers in elderly patients with heart failure Heart, September 1, 2002; 88(3): 239 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hulsmann, R. Berger, B. Sturm, A. Bojic, W. Woloszczuk, J. Bergler-Klein, and R. Pacher Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure Eur. Heart J., June 1, 2002; 23(11): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sharma and S.D. Anker The 6-minute walk test and prognosis in chronic heart failure -- the available evidence Eur. Heart J., March 2, 2001; 22(6): 445 - 448. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||